Sagamore Investments

Neat Limited, founded in 2015 and based in Wan Chai, Hong Kong, develops and offers the finance application Neat, which enables users to open mobile current accounts. The company provides the Neat Card, a prepaid MasterCard for payments in multiple currencies at both traditional and online merchants worldwide. Neat's offerings include business products such as dedicated Hong Kong bank account numbers, an online dashboard for financial management, current accounts for paying invoices and employees, and expense cards for staff. For personal use, Neat offers mobile current accounts, ATM cards, MasterCards for shopping and cash withdrawals, and online money transfer services. The company is designed to support entrepreneurs in the new economy, providing a modern alternative to traditional banking with a focus on international business needs.

Neat Limited, founded in 2015 and based in Wan Chai, Hong Kong, develops and offers the finance application Neat, which enables users to open mobile current accounts. The company provides the Neat Card, a prepaid MasterCard for payments in multiple currencies at both traditional and online merchants worldwide. Neat's offerings include business products such as dedicated Hong Kong bank account numbers, an online dashboard for financial management, current accounts for paying invoices and employees, and expense cards for staff. For personal use, Neat offers mobile current accounts, ATM cards, MasterCards for shopping and cash withdrawals, and online money transfer services. The company is designed to support entrepreneurs in the new economy, providing a modern alternative to traditional banking with a focus on international business needs.

Stealth BioTherapeutics is a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of innovative therapies targeting diseases associated with mitochondrial dysfunction. Founded in 2006 and headquartered in George Town, the Cayman Islands, the company’s lead product candidate, Elamipretide, aims to address both rare genetic and common age-related mitochondrial diseases. Additionally, Stealth BioTherapeutics is developing SBT-20, a small peptide designed to stabilize mitochondrial structure and function under oxidative stress, and SBT-272, which is being evaluated for its potential in treating rare neurodegenerative disorders, including amyotrophic lateral sclerosis. By focusing on mitochondrial health, Stealth BioTherapeutics seeks to improve outcomes for patients suffering from these challenging conditions.

Wecash, founded in October 2013, is a fintech company that is transforming the financial interactions of consumers globally. With a user base exceeding 160 million, Wecash has developed a credit assessment platform that utilizes data mining and machine learning algorithms. This platform allows users to submit their information through a mobile app and receive a credit evaluation within three minutes. By providing timely credit assessments, Wecash enables users to access a range of services, including capital borrowing and lending, as well as rentals for cars and houses, and opportunities for travel and education. The company aims to enhance the digital banking, spending, and saving experiences in markets such as Europe, Brazil, and Southeast Asia.

Momenta is an autonomous driving startup based in Beijing that specializes in developing advanced software solutions for full autonomy in vehicles. The company leverages deep learning technologies for perception, high-definition semantic mapping, and data-driven path planning, providing multi-level autonomous driving solutions alongside big data products and services. Momenta's team includes leading experts in computer vision and deep learning, contributing to the company's innovative approach to autonomous driving. Their technology is designed to enhance driving efficiency and safety, aiming to improve the overall experience for users through artificial intelligence.

Accion, established in 1961, is a global non-profit organization headquartered in Cambridge, Massachusetts. Its mission is to provide access to financial tools and services for underserved individuals, small businesses, and communities, enabling them to grow and thrive. Accion achieves this by catalyzing financial service providers to deliver affordable, high-quality solutions at scale. The organization supports these providers through advisory services, targeted coaching, and startup support, as well as providing high-caliber governance through board oversight. Additionally, Accion invests in and supports innovative fintech startups that drive financial inclusion through its Venture Lab initiative. This involves providing flexible financial and non-financial support, including investment capital and strategic operational assistance, to seed-stage startups leveraging technology and new business models to improve access to, and the quality of, financial services for the underserved.